BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

National Institute for Clinical Excellence (NICE) 

MidCity Place
71 High Holborn
London    WC1V 6NA  United Kingdom
Phone: 44-0-20-7067-5800 Fax: 44-0-20-7067-5801


SEARCH JOBS




Industry
Government

Segment
Research





 Company News
National Institute for Clinical Excellence (NICE) Reverses October Decision And Approves Roche (RHHBY)'s Oncology Drug Gazyvaro 12/2/2014 9:15:09 AM
Alexion Pharmaceuticals Inc. (ALXN) Release: National Institute for Clinical Excellence (NICE) Issues Final Positive Recommendation For National Commissioning Of Soliris® (Eculizumab) For All Patients With aHUS In England 12/1/2014 12:09:06 PM
National Institute for Clinical Excellence (NICE) Requests More Info On Novartis AG (NVS)'s Xolair To Treat Chronic Hives 11/19/2014 6:18:36 AM
UPDATE - Avita Medical Provides National Institute for Clinical Excellence (NICE) Guidance Recommendation Update 11/13/2014 11:20:52 AM
Onxeo Reaches Second Milestone Of BPIFrance Grant Dedicated To Livatag® Development As Part Of National Institute for Clinical Excellence (NICE) Consortium 10/13/2014 11:11:30 AM
National Institute for Clinical Excellence (NICE) Rejects Another Roche (RHHBY) Leukemia Drug Citing Data Uncertainties 10/3/2014 6:21:50 AM
National Institute for Clinical Excellence (NICE) Rejects Celgene (CELG)'s Abraxane For Pancreatic Cancer Over Limited Benefits, Cost 9/9/2014 5:58:09 AM
National Institute for Clinical Excellence (NICE) Recommends Commissioning Of Eculizumab (Soliris®) For All Patients With aHUS In England 9/4/2014 11:47:17 AM
Another Controversial High Price Med: National Institute for Clinical Excellence (NICE) Rejects Roche (RHHBY)'s New $152,850 Breast Cancer Drug 8/8/2014 5:54:23 AM
Daiichi Sankyo, Inc. (4568.t) And Eli Lilly and Company (LLY): Heart Patients In England And Wales Offered More Choice Of Therapies As National Institute for Clinical Excellence (NICE) Extends Recommendations For Prasugrel 7/23/2014 11:01:12 AM
12345678910...